Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Antibiotice logo — Cu știință și suflet alături de oameni!

Antibiotice

Cu știință și suflet alături de oameni!

Founded 1955 Romania Romania 575 employees Post-IPO Debt Total: $25.00M Pharmaceutical

General Information

Company Name Antibiotice
Founded Year 1955
Location Romania Romania
Employees 575
Industries Pharmaceutical
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Antibiotice. To contact Antibiotice, visit antibiotice.ro.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Antibiotice compare?

A PDF of Antibiotice and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Antibiotice soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Antibiotice

Antibiotice is a prominent Romanian pharmaceutical company that has been an integral part of the industry since its establishment in 1955. The company's slogan, "Cu știință și suflet alături de oameni!," embodies its commitment to scientific advancement and compassion towards humanity. Specializing in the production of a wide range of pharmaceutical substances, including generic drugs for human and veterinary use, as well as the active ingredient Nystatin, Antibiotice has established itself as a key player in the field. With a diverse product portfolio comprising 160 generic drugs catering to various medical needs such as infectious diseases, cardiovascular, dermatological, digestive, and central nervous system-related pathologies, Antibiotice serves both the domestic and international markets. The company's reach extends to over 70 countries worldwide, earning it a prominent position in the global pharmaceutical landscape. Notably, Antibiotice holds the top spot globally in the production of Nystatin's active ingredient and is a leading manufacturer of antiinfective generic drugs in Romania, offering competitively priced medications with a focus on affordability and accessibility. Antibiotice's commitment to quality standards is evident through its adherence to internationally recognized certifications such as Good Manufacturing Practice (EU-GMP), Certificate of compliance with European Pharmacopoeia (COS), and Food and Drug Administration authorization (FDA). These certifications underscore the company's dedication to upholding superior quality across its operations, enabling its expansion into international markets and fostering trust among consumers and healthcare providers. Noteworthy is Antibiotice's recent €25.00M Post-IPO Debt investment on 10 November 2023, with the European Investment Bank (EIB) as the investor. This investment underscores the confidence of institutional investors in Antibiotice's growth potential and its continued contribution to the pharmaceutical industry. With its rich history, commitment to quality, and strategic investments, Antibiotice is poised to further enhance its global presence and make significant contributions to healthcare systems worldwide.

Business keywords: pharmaceutical manufacturer, generic drugs, antibiotics, Nystatin, international market, quality standards, GMP, European Pharmacopoeia, FDA authorization, healthcare system, veterinary drugs, active ingredients

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt €25.00M 1
European Investment Bank
10 Nov 2023

Antibiotice Alternatives & Competitors

View All Alternatives
Antibiotice vs
AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD India

Committed to healthier life!

14923 employees
Biotechnology, Pharmaceutical
Compare Antibiotice vs AUROBINDO PHARMA LTD
Antibiotice vs
Grindeks
Grindeks Latvia

We make people’s lives healthier and easier. Simple and innovative solutions to improve quality of l...

408 employees
Manufacturing, Pharmaceutical
Antibiotice vs
Moehs Iberica
Moehs Iberica Spain

Active ingredients for pharmaceutical market

215 employees
Manufacturing, Pharmaceutical
View all alternatives

FAQ About Antibiotice

Cu știință și suflet alături de oameni!
Antibiotice was founded in 1955.
Antibiotice is headquartered in Romania.
Antibiotice operates in Pharmaceutical. Its work centres on pharmaceutical manufacturer, generic drugs, antibiotics and Nystatin.
Antibiotice has approximately 575 employees.
Antibiotice has completed 1 funding round, raising a total of $25.00M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Antibiotice include AUROBINDO PHARMA LTD, Grindeks, Moehs Iberica, S.A.L.F. S.P.A. LABORATORIO FARMACOLOGICO, Unipharma Syria. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antibiotice and AUROBINDO PHARMA LTD are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Antibiotice, https://bouncewatch.com/company/antibiotice, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes